Phase I study of single-agent CC-292, a highly selective...

Haematologica 2016 / 07 Vol. 101; Iss. 7

Phase I study of single-agent CC-292, a highly selective Brutons tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia

Brown, J. R., Harb, W. A., Hill, B. T., Gabrilove, J., Sharman, J. P., Schreeder, M. T., Barr, P. M., Foran, J. M., Miller, T. P., Burger, J. A., Kelly, K. R., Mahadevan, D., Ma, S., Li, Y., Pierce, D
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
101
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2015.140806
Date:
July, 2016
File:
PDF, 1.05 MB
english, 2016
Conversion to is in progress
Conversion to is failed